Obesity White Papers & Case Studies

  1. Data-Driven Strategies To Advance Development And Approval Of Rare/Ultra-Rare Disease Therapies 5/22/2026

    Explore how integrated regulatory, statistical, and operational expertise can be applied to help sponsors navigate complex development pathways and accelerate global approvals.

  2. Site Selection And Incentives Advisory 5/20/2026

    Maximize growth with strategic site selection and incentives advisory that help reduce project costs and optimize expansion, unlocking long-term business value.

  3. Delivering Complex Oncology Trials At Scale 5/19/2026

    Parexel delivered two complex, global Phase III prostate cancer trials by aligning site selection, logistics, imaging workflows, and RAM regulatory expertise—achieving faster enrollment and on‑time execution.

  4. A Digital Health Solution For Continuous, Long-Term Cough Monitoring 5/15/2026

    The way we measure respiratory symptoms is changing. Explore the effects of combining AI-powered cough detection with wearable digital health technology for continuous, long-term cough monitoring

  5. Optimizing Wearable Adherence In A Phase 3 Oncology Trial 5/15/2026

    Long-term wearable monitoring only works if patients keep wearing the device, and in oncology trials, that’s easier said than done.

  6. Reduce Avoidable Protocol Amendments By Anticipating Operational Pitfalls 5/13/2026

    This report examines how amendment drivers vary across therapeutic areas and how those changes impact execution, patient burden, site workload, timelines, and study costs.

  7. 5 Questions Sponsors Must Ask Before Selecting A Randomization Partner 5/12/2026

    Choose the right IRT partner for complex master protocols. Learn how adaptive randomisation expertise and flexible technology reduce disruption and keep trials execution-ready.

  8. Patient Liaison: Per-Visit Participant Support 5/12/2026

    Dedicated Patient Liaison support helps coordinate participant travel, reimbursements, and visit logistics so sites stay focused and study requests keep moving forward.

  9. Retention And Access In NSCLC Clinical Trials 5/12/2026

    Helping participants navigate respiratory limitations, fatigue, and complex visit schedules in Non-Small Cell Lung Cancer (NSCLC) studies.

  10. The State Of Materiovigilance: Capability Gaps, Technology Momentum, And Outsourcing Readiness 5/12/2026

    Explore how pharma and biotech companies are using AI, outsourcing, and new technologies to strengthen materiovigilance for complex drug-device products.